Saša Masleša-Galić

Recombinant bacillus Calmette–Guérin (BCG) vaccines expressing the <i>Mycobacterium tuberculosis</i> 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model

Marcus A. Horwitz, Günter Harth, Barbara Jane Dillon et al. · Proceedings of the National Academy of Sciences · 2000 · 435 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A Replication-Limited Recombinant <i>Mycobacterium bovis</i> BCG Vaccine against Tuberculosis Designed for Human Immunodeficiency Virus-Positive Persons Is Safer and More Efficacious than BCG

Michael V. Tullius, Günter Harth, Saša Masleša-Galić et al. · Infection and Immunity · 2008 · 82 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Drug regimens identified and optimized by output-driven platform markedly reduce tuberculosis treatment time

Bai‐Yu Lee, Daniel L. Clemens, Aleidy Silva et al. · Nature Communications · 2017 · 69 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters

Qingmei Jia, Helle Bielefeldt‐Ohmann, Rachel M. Maison et al. · npj Vaccines · 2021 · 64 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Commonly administered BCG strains including an evolutionarily early strain and evolutionarily late strains of disparate genealogy induce comparable protective immunity against tuberculosis

Marcus A. Horwitz, Günter Harth, Barbara Jane Dillon et al. · Vaccine · 2008 · 49 citations · Full text

Life Sciences, Immunology, Microbiology +11